This announcement is a separate document:
百诚医药：独立董事2023年度述职报告（李会林）
Baicheng Pharmaceutical: Independent Director's 2023 Debriefing Report (Li Huilin)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.